Literature DB >> 21097488

Changes in serum concentrations of soluble vascular endothelial growth factor receptor-1 after pregnancy.

K-A Wathén1, J Sarvela, F Stenman, U-H Stenman, P Vuorela.   

Abstract

BACKGROUND: Vascular endothelial growth factor (VEGF) is the most potent stimulator of angiogenesis. It mediates its activity through two membrane-bound receptors, VEGFR-1 and VEGFR-2, both expressed in the placenta. Beginning in early pregnancy, the soluble form of the first, sVEGFR-1, binds and inhibits most of the biological actions of circulating VEGF. After delivery, it disappears from the maternal circulation.
METHODS: We determined the biological elimination rate of endogenous sVEGFR-1 after term pregnancy in serial venous samples obtained during and after elective Caesarean sections (n=8), and we demonstrated the relationship between serum sVEGFR-1 and VEGF after mid-trimester legal termination of pregnancy (n = 5), by analysing their concentrations using immunoassays (ELISA).
RESULTS: The disappearance of sVEGFR-1 from circulation after Caesarean delivery was biphasic with a rapid half-life of 3.4 h (2.2-7.5 h; median, range) and a slow one of 29 h (17-94 h). After mid-trimester legal termination of pregnancy the sVEGFR-1 concentrations decreased and those of free VEGF simultaneously increased with a highly significant negative correlation with each other (r = -0.90, P < 0.0001).
CONCLUSIONS: The disappearance of endogenous sVEGFR-1 after pregnancy is biphasic, and it is associated with a simultaneous increase in free VEGF concentrations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21097488     DOI: 10.1093/humrep/deq304

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  4 in total

1.  Hypoxia inducible factors-mediated inhibition of cancer by GM-CSF: a mathematical model.

Authors:  Duan Chen; Julie M Roda; Clay B Marsh; Timothy D Eubank; Avner Friedman
Journal:  Bull Math Biol       Date:  2012-10-17       Impact factor: 1.758

2.  Placental growth factor blunts uterine artery responses to angiotensin II.

Authors:  J Espinoza; A Betancourt; M A Belfort; A A Shamshirsaz; K A Fox; C Yallampalli
Journal:  BJOG       Date:  2019-03-18       Impact factor: 6.531

3.  Involvement of tumor macrophage HIFs in chemotherapy effectiveness: mathematical modeling of oxygen, pH, and glutathione.

Authors:  Duan Chen; Andrey A Bobko; Amy C Gross; Randall Evans; Clay B Marsh; Valery V Khramtsov; Timothy D Eubank; Avner Friedman
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

Review 4.  Peripartum Cardiomyopathy: an Update.

Authors:  Feriel Azibani; Karen Sliwa
Journal:  Curr Heart Fail Rep       Date:  2018-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.